过去一年中添加的文章，按日期排序
[PDF][PDF] Lurking Danger: Emerging Evidence
PB Gopal - … of Critical Care Medicine: Peer-reviewed, Official …, 2024 - ijccm.org
144 天前 - … more onto fecal microbiota transplantation, which is offered for recurrent and
refractory CDAD and … new drug application. In November 2022, USFDA approved the first-ever …
refractory CDAD and … new drug application. In November 2022, USFDA approved the first-ever …